amgenesas.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Sitemap: | ||
Meta Tags
| Title | Home | Amgen ESA | |
| Description | Every vial tells a Learn about Amgen ESAs as a treatment for anemia due to chronic kidney disease (CKD) for |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 35.162.214.198 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
amgenesas.com Valuation
|
US$2,571,931
Last updated: 2023-05-12 09:26:34
amgenesas.com has Semrush global rank of 4,115,315. amgenesas.com has an estimated worth of US$ 2,571,931, based on its estimated Ads revenue. amgenesas.com receives approximately 296,762 unique visitors each day. Its web server is located in United States, with IP address 35.162.214.198. According to SiteAdvisor, amgenesas.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,571,931 |
| Daily Ads Revenue | US$2,375 |
| Monthly Ads Revenue | US$71,223 |
| Yearly Ads Revenue | US$854,673 |
| Daily Unique Visitors | 19,785 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| amgenesas.com. | A | 299 | IP: 35.162.214.198 |
| amgenesas.com. | A | 299 | IP: 35.83.98.228 |
| amgenesas.com. | NS | 86400 | NS Record: ns-1323.awsdns-37.org. |
| amgenesas.com. | NS | 86400 | NS Record: ns-1624.awsdns-11.co.uk. |
| amgenesas.com. | NS | 86400 | NS Record: ns-299.awsdns-37.com. |
| amgenesas.com. | NS | 86400 | NS Record: ns-557.awsdns-05.net. |
HtmlToTextCheckTime:2023-05-12 09:26:34
| Indications ARANESP ® (darbepoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD), including patients on dialysis and patients not on dialysis. EPOGEN ® (epoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD) in patients on dialysis to decrease the need for READ MORE EPOGEN ® (epoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD) in patients on dialysis to decrease the need for red blood cell (RBC) transfusion. Limitations of Use: ARANESP ® and EPOGEN ® have not been shown to improve quality of life, fatigue, or patient well-being. ARANESP ® and EPOGEN ® are not indicated for use as a substitute for RBC transfusions in patients who require immediate correction of anemia. Home | Amgen ESA | HCP For Patients ARANESP ® EPOGEN ® Prescribing Information ARANESP ® EPOGEN ® Important Safety Information ARANESP ® EPOGEN ® Medication Guide ARANESP ® EPOGEN ® ESA Story ARANESP ® |
HTTP Headers
HTTP/1.1 403 Forbidden Server: awselb/2.0 Date: Sat, 11 Dec 2021 08:29:58 GMT Content-Type: text/html Content-Length: 118 Connection: keep-alive |
amgenesas.com Whois Information
Domain Name: AMGENESAS.COM Registry Domain ID: 2613214529_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-05-27T16:02:10Z Creation Date: 2021-05-18T21:33:22Z Registry Expiry Date: 2023-05-18T21:33:22Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1323.AWSDNS-37.ORG Name Server: NS-1624.AWSDNS-11.CO.UK Name Server: NS-299.AWSDNS-37.COM Name Server: NS-557.AWSDNS-05.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-11T08:11:08Z <<< |